ArticleDigestive diseases and sciences2023

Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease.

Nisha B Shah et al.PubMed ↗Publisher ↗

No numbers read from the abstract.